EchoMD Automated Ejection Fraction Software vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bay Labs (now Caption Health)
VS
by Volta Medical

AI Verdict

Tool A is designed to enhance the efficiency and accuracy of echocardiogram interpretation by automating ejection fraction calculations, making it suitable for diagnostic cardiology and imaging departments. Tool B, however, provides real-time AI assistance to electrophysiologists during cardiac ablation procedures, focusing on identifying abnormal electrograms. While both are cardiology AI tools, their distinct applications in diagnostic imaging versus interventional electrophysiology mean they address different clinical needs and workflows.

Choose EchoMD Automated Ejection Fraction Software if…

Choose EchoMD Automated Ejection Fraction Software if your primary need is to enhance the efficiency and accuracy of cardiac evaluations through automated echocardiogram analysis. This tool is ideal for clinics and hospitals seeking to streamline the process of calculating left ventricular ejection fraction and reduce variability in measurements during diagnostic assessments.

View EchoMD Automated Ejection Fraction Software →

Choose VX1+ if…

Choose VX1+ if you require real-time AI-powered assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to help electrophysiologists identify abnormal electrograms and guide ablation strategies directly within the operating environment.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EchoMD Automated Ejection Fraction Software VX1+
Pricing Contact for pricing Unknown
Deployment On-premise (via DICOM PACS integration) Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize seamless integration into existing clinical workflows. Tool A integrates with DICOM PACS for automated measurements, while Tool B features a 'simple user interface with color coding' for real-time guidance in the EP lab. Without direct user feedback, both appear to prioritize ease of use within their specific contexts.

Clinical Value

VX1+

While Tool A significantly improves the accuracy and efficiency of a critical diagnostic measurement (EF), Tool B provides real-time, AI-driven insights during complex interventional procedures (AF/AT ablation). Clinical studies for VX1+ suggest improved procedural outcomes and reduced recurrence rates, indicating a more direct and potentially transformative impact on patient treatment success.

Pricing & Value

Tie

Neither tool provides public pricing information, making a direct comparison impossible. Both offer strong value propositions: Tool A through efficiency and accuracy in diagnostics, and Tool B through potentially improved success rates in high-cost, complex therapeutic procedures. Without specific pricing, it's impossible to determine which offers better value for money.

Enterprise Readiness

EchoMD Automated Ejection Fraction Software

Both tools are FDA cleared and integrate with existing hospital systems. However, Tool A explicitly states HIPAA compliance and leverages standard DICOM PACS integration, a universal enterprise backbone for imaging. Tool B's compliance is 'expected' and its integration is specific to EP lab systems, giving Tool A a slight edge in documented and broadly applicable readiness.

Innovation

VX1+

While Tool A was innovative in automating EF calculation and AI-guided ultrasound acquisition, Tool B's application of AI for real-time, complex pattern identification and guidance during an invasive therapeutic procedure represents a higher degree of innovation. Its ability to provide live decision support in a highly specialized and critical interventional setting is particularly cutting-edge.

Support & Docs

Tie

The provided facts do not contain any specific information regarding support services or documentation for either Tool A or Tool B. Therefore, based on the available data, it is not possible to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EchoMD Automated Ejection Fraction Software VX1+
Name EchoMD Automated Ejection Fraction Software VX1+
Company Bay Labs (now Caption Health) Volta Medical
Tagline AI-powered automated ejection fraction calculation for echocardiograms. Transforming EP Data into AI Solutions
Primary Function Automatically selects optimal echocardiogram clips and calculates left ventricular ejection fraction (EF). Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures.
Target Specialties Cardiology, Critical Care, Emergency Medicine, Radiology Cardiology
Key AI Application Automated clip selection and Left Ventricular Ejection Fraction (EF) calculation using deep learning algorithms. Real-time identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures.

Videos

Demos, reviews, and walkthroughs featuring EchoMD Automated Ejection Fraction Software and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EchoMD Automated Ejection Fraction Software is designed to improve efficiency and accuracy in general cardiac evaluation by automatically calculating left ventricular ejection fraction (EF) from echocardiograms. In contrast, VX1+ is specifically developed to assist electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for patients with atrial fibrillation (AF) and atrial tachycardia (AT).
EchoMD Automated Ejection Fraction Software is deployed on-premise and integrates seamlessly with DICOM PACS medical imaging environments. VX1+ is a software application that runs on a computing platform and integrates with existing EP recording and 3D mapping systems, including compatibility with existing 510(k)-cleared catheters and specific data acquisition systems such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
EchoMD Automated Ejection Fraction Software utilizes deep learning algorithms for image analysis to automatically select optimal echocardiogram clips, rate image quality, and calculate Left Ventricular Ejection Fraction (EF), reducing the need for manual selection and manipulation. VX1+ provides AI-driven insights for real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart, identifying spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, and includes a booster mode for increased sensitivity and cycle length estimation.
EchoMD Automated Ejection Fraction Software processes echocardiogram clips, providing automated Left Ventricular Ejection Fraction (EF) calculations, image quality ratings, and selected best clips as its output. VX1+ analyzes electrogram data from EP recording and 3D mapping systems, offering real-time annotations and color-coded identification of dispersed electrograms (DEs) on 3D maps, along with cycle length estimations.
EchoMD Automated Ejection Fraction Software aims to increase efficiency in echocardiogram interpretation and reduce variability in EF measurement compared to manual methods, thereby improving accuracy in cardiac evaluation. VX1+ aims to assist electrophysiologists by providing real-time AI-driven insights for identifying abnormal electrograms during ablation procedures, potentially enhancing the effectiveness of AF and AT treatments by precisely pinpointing optimal ablation locations.
EchoMD Automated Ejection Fraction Software was developed by Bay Labs, which is now known as Caption Health. VX1+ is developed by Volta Medical.
AI Tool Finder
AI-powered search. Results may not be comprehensive.